OCX OCX

Oncocyte Stock Price

1.68
0.00 (0.0%)
1.68
Volume 0
Bid Price 1.30
Ask Price 2.25
News -
Day High

Low
1.6086

52 Week Range

High
6.25

Day Low
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Oncocyte Corporation OCX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 1.68 04:00:00
Open Price Low Price High Price Close Price Prev Close
1.68
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 1.68 USD

Period:

Draw Mode:

Oncocyte Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 154.95M 92.23M 60.72M $ 1.22M $ - -0.47 -4.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 160.00k 5.30%

more financials information »

Oncocyte News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical OCX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.69341.951.60861.78814,045-0.0134-0.79%
1 Month2.102.26411.60861.92654,176-0.42-20.0%
3 Months3.623.701.60862.27552,155-1.94-53.59%
6 Months5.195.481.60863.33566,807-3.51-67.63%
1 Year3.496.251.60864.06577,695-1.81-51.86%
3 Years3.496.251.60864.06577,695-1.81-51.86%
5 Years3.496.251.60864.06577,695-1.81-51.86%

Oncocyte Description

OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. It develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, the company also developing screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers. Geographically operation of the group is carried through United States and it earns revenue from the sale of diagnostic tests.


Your Recent History
NASDAQ
OCX
Oncocyte
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.